🧠This Week in Immunology: New Approvals & Breakthroughs in Autoimmune Treatment
Stay up to date with the latest immunology news, featuring exciting approvals and clinical trial results:
💥 Tremfya (Guselkumab) approved for Crohn’s Disease by the European Commission.
🏅 EULAR updates recommendations for antirheumatic drugs during pregnancy.
🤔 Arcutis’ Zoryve foam shows strong results for scalp and body psoriasis, with FDA review underway.
🌿 Icotrokinra demonstrates significant skin clearance in challenging psoriasis areas.
đź’‰ Innovo Therapeutics reports promising Phase 1 results for INV-101 in autoimmune diseases.
🚀 Kymera’s KT-579 shows superior efficacy in preclinical models for autoimmune conditions.
Stay ahead in Immunology research!
âś… Like, share, and subscribe for weekly updates on the latest in Immunology and autoimmune diseases.
âś… Visit www.lqventures.com for expert healthcare insights and consulting services.
#Immunology #FDAApproval #PsoriasisTreatment #AutoimmuneResearch #HealthcareInnovations #CrohnsDisease #ClinicalTrials #ImmunologyNews